A consortium of University of Birmingham researchers, clinicians and industry partners is developing a novel device that could revolutionize the clinical management of anal fistula. In this intrusive ...
A consortium of Birmingham researchers, clinicians and industry partners has received a second £1.1m award from the National Institute for Health and Care Research (NIHR) for a three-year study ...
The U.S. FDA granted Signum Surgical Ltd. de novo marketing clearance for its Biohealx technology as a treatment for anal fistula. Biohealx is a single use, bioabsorbable implant, designed to not only ...
GALWAY, Ireland--(BUSINESS WIRE)--Signum Surgical, a medical technology company dedicated to advancing the treatment of colorectal diseases, today announced the publication of first-in-human clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results